Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Conferences, Workshops, Symposiums, and Seminars
  4. A miRNA-Based Gene Therapy Approach to Target Mutated SOD1 in Key Cell Types in Amyotrophic Lateral Sclerosis {ALS}
 
conference paper

A miRNA-Based Gene Therapy Approach to Target Mutated SOD1 in Key Cell Types in Amyotrophic Lateral Sclerosis {ALS}

Vilmont, Valerie  
May 1, 2018
Molecular Therapy
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
  • Details
  • Metrics
Type
conference paper
Web of Science ID

WOS:000435342203124

Author(s)
Vilmont, Valerie  
Date Issued

2018-05-01

Publisher

CELL PRESS

Publisher place

Cambridge

Published in
Molecular Therapy
Volume

26

Issue

5

Start page

263

End page

263

Subjects

Biotechnology & Applied Microbiology

•

Genetics & Heredity

•

Medicine, Research & Experimental

•

Biotechnology & Applied Microbiology

•

Genetics & Heredity

•

Research & Experimental Medicine

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LEN  
Event nameEvent placeEvent date
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Chicago, IL

May 16-19, 2018

Available on Infoscience
December 13, 2018
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/151852
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés